The global cardiovascular needle market witnessed robust growth, reaching a valuation of approximately USD 85.2 Million by the end of 2021. A comprehensive analysis by FMI projects a steady Compound Annual Growth Rate (CAGR) of 7.5% for the market, foreseeing it to exceed USD 188.4 Million by 2032. Cardiovascular diseases (CVDs) encompass a spectrum of …